Related Experiment Videos
[Network for sentinel lymph node research in breast cancer]
Jean-François Delaloye1, Jean-François Monod, Anne Friedli
1Département de Gynécologie et d'Obstétrique, CHUV, Lausanne.
Revue Medicale De La Suisse Romande
|April 21, 2004
Summary
Sentinel node biopsy accurately predicts axillary nodal status in early breast cancer patients. Implementing a network facilitates sentinel node biopsy discovery in general practice.
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Early-stage breast cancer management often involves assessing axillary lymph node involvement.
- Sentinel node biopsy (SNB) is a minimally invasive technique to stage the axilla.
Purpose:
- To assess the accuracy of SNB in predicting axillary nodal status.
- To evaluate the feasibility of integrating SNB into general practice settings.
Summary:
- A study of 304 early breast cancer patients demonstrated a 99% detection rate and 98% intraoperative identification accuracy for SNB.
- SNB correctly identified nodal involvement in 25% of cases, with a 0% false-negative rate and 100% negative predictive value.
- Histopathological analysis included serial sectioning with hematoxylin and eosin staining, alongside cytokeratin immunohistochemistry.
Impact:
- SNB is a highly accurate method for staging axillary lymph nodes in early breast cancer.
- Establishing a network can enhance the successful implementation and accessibility of SNB in routine clinical practice.